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Abstract
Introduction: Subchondral bone cysts (SBC) have been identified in patients with knee osteoarthritis (OA) as a cause of
greater pain, loss of cartilage and increased chance of joint replacement surgery. Few studies monitor SBC
longitudinally, and clinical research using three-dimensional imaging techniques, such as magnetic resonance imaging
(MRI), is limited to retrospective analyses as SBC are identified within an OA patient cohort. The purpose of this study
was to use dual-modality, preclinical imaging to monitor the initiation and progression of SBC occurring within an
established rodent model of knee OA.
Methods: Eight rodents underwent anterior cruciate ligament transection and partial medial meniscectomy (ACLX)
of the right knee. In vivo 9.4 T MRI and micro-computed tomography (micro-CT) scans were performed
consecutively prior to ACLX and 4, 8, and 12 weeks post-ACLX. Resultant images were co-registered using
anatomical landmarks, which allowed for precise tracking of SBC size and composition throughout the study. The
diameter of the SBC was measured, and the volumetric bone mineral density (vBMD) was calculated within the
bone adjacent to SBC. At 12 weeks, the ACLX and contralateral knees were processed for histological analysis,
immunohistochemistry, and Osteoarthritis Research Society International (OARSI) pathological scoring.
Results: At 4 weeks post-ACLX, 75% of the rodent knees had at least 1 cyst that formed in the medial tibial
plateau; by 12 weeks all ACLX knees contained SBC. Imaging data revealed that the SBC originate in the presence
of a subchondral bone plate breach, with evolving composition over time. The diameter of the SBC increased
significantly over time (P = 0.0033) and the vBMD significantly decreased at 8 weeks post-ACLX (P = 0.033).
Histological analysis demonstrated positive staining for bone resorption and formation surrounding the SBC, which
were consistently located beneath the joint surface with the greatest cartilage damage. Trabecular bone adjacent
the SBC lacked viable osteocytes and, combined with bone marrow changes, indicated osteonecrosis.
Conclusions: This study provides insight into the mechanisms leading to SBC formation in knee OA. The expansion of
these lesions is due to stress-induced bone resorption from the incurred mechanical instability. Therefore, we suggest
these lesions can be more accurately described as a form of OA-induced osteonecrosis, rather than ‘subchondral cysts’.
Introduction
Osteoarthritis (OA) is an articular joint disorder that
leads to mechanical failure within the knee, causing pain
and deformity. Although this degenerative joint disease
is common throughout North America [1-3], there is an
unmet need for pharmacological therapies that modify
or reverse the structural damage and alleviate symptoms
[4]. The erosion of cartilage (that is, full thickness
lesions or loss of surface integrity) is commonly asso-
ciated with OA [5,6]. However, changes to the underly-
ing subchondral bone, through variations in regional
volumetric bone mineral density (vBMD) or the rapid
unorganized remodeling seen after injury, are likely to
cause greater structural damage to joints by inhibiting
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local blood flow [7] and the formation of sclerosis [8,9].
Moreover, it has been shown that alterations in the bio-
mechanical integrity of subchondral bone can modify
the ability of the overlying cartilage to function normally
[4,10,11]. Identifying pathological features within
patients exhibiting aggressive disease progression is
paramount to ensuring the proper treatment regimen is
used, whether that includes physical therapy, pharmaco-
logical or surgical interventions [12].
Intra-osseous lesions, commonly known as subchon-
dral bone cysts (SBC), ‘pseudo-cysts’ or ‘geodes’ [13,14],
within OA knees have recently been associated with
greater pain and disease progression. SBC were first iden-
tified by Ondrouch [15] and Landells [16] in the load-
bearing regions of the femur, patella, and shoulder of
arthritic patients, although the exact cause is not well
known. Currently, there are two conflicting theories pro-
posed for the origin of SBC in OA: ‘synovial fluid intru-
sion’, via a breach in the subchondral plate caused by the
diminished local cartilage, leading to a rapid inflamma-
tory response; or ‘bony contusion’, where stresses in the
bone below the joint surface (due to trauma or thinned
cartilage) exceed the functional strength of the trabecular
bone, causing micro-fracture, edema, and focal bone
resorption [14,15,17]. However, those earlier studies only
utilized histological techniques, and were limited to ana-
lyzing tissue that was removed during a surgical proce-
dure, such as total knee replacement [18], where the
diseased or lesion-occupied area is severely degraded.
Concurrently, the ability to monitor the progression of
these cystic lesions in vivo has been limited to retrospec-
tive analyses of patients’ MRI scans [18-21] which pro-
vide limited information regarding the onset of SBC
formation. Given recent evidence that associates the pre-
sence of SBC, found in 25% to 47% of painful OA knees,
with greater cartilage loss and increased risk of joint
replacement among OA patients [19,21], it is apparent
that this subchondral bone feature warrants further
study.
Pre-clinical models can provide valuable insights into
the cause of SBC by producing patterns of cartilage and
bone degeneration that are similar to those seen in
human post-traumatic or secondary OA. The surgical
induction of a partial medial meniscectomy, combined
with a severed anterior cruciate ligament (ACLX), in the
rodent knee can emulate several aspects of secondary
OA (including SBC) in a predictable and reproducible
manner [22,23]. The use of preclinical imaging, specifi-
cally micro-computed tomography (micro-CT), has
become routine in the past several years for longitudi-
nal, in vivo monitoring of disease progression [24].
When combined with the superior soft-tissue contrast
provided by high-field magnetic resonance imaging
(MRI) [25,26], dual-modality imaging has the potential
to characterize joint degradation comprehensively [23]
and differentiate the bone, fluid, and tissue components
found within SBC [16]. However, few studies have capi-
talized on the ability to incorporate image registration,
which ensures any observations are conducted at the
same three-dimensional (3D) location within each
volume.
The purpose of this study was to use dual-modality,
in vivo micro-imaging techniques to monitor the devel-
opment of intra-osseous lesions occurring in an estab-
lished pre-clinical model of OA. By combining our
quantitative measurements with end-stage histology and
immunohistochemistry, we intend to accurately deter-
mine the contents within these SBC and identify the
possible existence of an open communication between
the subchondral bone and joint space. Thus, these
advanced analyses will provide valuable insight into the
origin of OA SBC through the possible confirmation of
one of the prevailing theories while simultaneously cap-
turing the progressive remodeling of osteoarthritic bone.
Furthermore, we hope to define more accurately this
increasingly prevalent condition that is associated with
more actively degenerative OA.
Materials and methods
Rodent model of secondary OA
As described previously, our preclinical model of OA
involves an anterior cruciate ligament transection with
partial medial meniscectomy (ACLX), performed on
male Sprague-Dawley rats [22,27]. The surgery involved
an incision through the medial joint compartment of the
right knee, with subsequent ligament bisection and
removal of the anterior horn of the medial meniscus. All
animal work was conducted in accordance with the
Canadian Council on Animal Care guideline, and
approved by the Animal Use Committee at the University
of Western Ontario. Eight rats (body weight = 416 ± 6 g,
mean ± SE) were used throughout the time-course of the
imaging experiments, and were permitted free activity
with food and water ad libitum between scanning ses-
sions. The rats were scanned with our dual-modality ima-
ging protocol prior to ACLX, and at 4, 8, and 12 weeks
post-ACLX.
In vivo 9.4 T MRI and micro-CT
A custom animal bed was used for both MRI and CT
scanning, where the rat’s hind limbs were secured to
inhibit any flexion of the knee between scans (Figure 1).
This bed could be detached and re-attached to either
scanner, allowing for quick transition between the MR
and CT scanner facilities with little change in rat knee
flexion.
All rats were anesthetized by an intramuscular injec-
tion of ketamine (100 mg/ml), xylazine (5 mg/ml) and
McErlain et al. Arthritis Research & Therapy 2012, 14:R26
http://arthritis-research.com/content/14/1/R26
Page 2 of 12
saline prior to imaging. The dose was maintained at 0.1
ml/100 g body mass for each successive imaging session.
High-field MRI images were acquired using an actively
shielded, horizontal 9.4 T scanner (Varian, Palo Alto, CA,
US). Slices were acquired in the sagittal plane with a 2
cm surface coil using a 3D FLASH sequence (256 ×
256 × 96 matrix, TE = 3.0 ms, TR = 10 ms, FA = 5.5, 12
averages, 25.6 × 25.6 × 9.6 mm3 field of view), which
required approximately 32 minutes of scan time. The
resultant 3D volume resolution was 0.1 × 0.1 ×
0.15 mm3. Once MRI was complete, the surface coil was
removed and a tissue-calibration phantom was placed
near the joint line, prior to micro-CT imaging. This
solid-state phantom contains a single insert that mimics
the radiographic properties of cortical bone (SB3, Gam-
mex RMI, Middleton, WI, US) which ensured the CT
data set would be scaled in Hounsfield units and cali-
brated in volumetric bone mineral density (vBMD, mg/
cm3 of hydroxyapatite) [22,28]. Micro-CT scans were
performed using a bench-top scanner (explore Locus,
General Electric Health Care, London, ON, CA) with the
following parameters: 210 views over 1° increments, 5
exposures averaged per view, 400 ms exposure time
using 80 kV and 0.45 mA, isotropic reconstructed voxels
with 0.045 mm dimensions, scan time approximately 17
minutes.
The reconstructed data sets were examined in multi-pla-
nar reformatted view and all measurements were per-
formed on a workstation using MicroView (v.2.11,
General Electric Healthcare, London, ON, CA) software.
Due to unequal voxel sizes between the MRI and micro-
CT data sets, the MRI data was resampled, using in-house
software, to an isotropic voxel dimension of 0.045 mm
which allowed for anatomical landmark-based, rigid-body
registration [25] and the creation of a dual-modality image
of the knee (Figure 2). The presence of cysts was detected
in all three anatomical planes, however, the coronal plane
was chosen when the maximum diameter of the lesion
was determined, which was defined as the maximum
extent of focal loss of bone in the medial-lateral direction
within the affected joint compartment. Thus, for each rat
knee volume per time point, the user identified the lesions
as focal areas of bone loss that were spherical or ellipsoidal
in shape and appeared adjacent to the joint surface of
either the femur or tibia. Upon verification that a SBC had
been identified within the dual-modality images, vBMD
measurements of the subchondral bone, in the region
between the SBC and the articular surface, were acquired
using the region of interest (ROI) tool within the micro-
CT volume. Cylindrical ROIs, with a diameter of 0.68 mm
and a height of 0.23 mm, were placed in the superficial
regions of bone and values for vBMD were calculated
within each rodent knee over time. Therefore, an accurate
depiction of the changes to the bone, which occurred in
vivo as OA progressed and the SBC modified its size, was
obtained. In addition, the maximal diameter of the lesion
was recorded from the CT data, while the corresponding
MRI section was utilized in an attempt to identify the het-
erogeneous tissue types, such as a fibrous or fluid-filled
cavity, that appeared within the lesion space. Finally, the
diameter of the SBC, occurring in each OA rat knee, was
compared between time points to allow for longitudinal
analysis of lesion size and any possible changes in SBC
composition.
Histological end-stage analysis
At 12 weeks post-ACLX, the rats were euthanized by an
intraperitoneal injection of pentobarbital (110 mg/kg
body weight). Both hind limbs were disarticulated and
decalcified in 15% EDTA/glycerol (pH = 7.3) for up to 5
weeks. The knee joints were subsequently embedded in
paraffin wax and the medial joint compartment was seri-
ally sectioned in the sagittal plane. Sections were
selected based on their proximity to the SBC that were
identified and measured from the medial bony joint
margin in the micro-CT images. A minimum of three
sections, each 5 μm thick, were stained with Safranin-O
and fast green, and the Osteoarthritis Research Society
International (OARSI) scoring method was used to
grade and stage OA degradation in the medial compart-
ment of both the ACLX and the contralateral knee [29].
The OA score was calculated by multiplying the grade
and stage values for each slide (a minimum score of 0
represents no OA degradation and a score of 24 repre-
sents the maximum degree of OA) and the total score
Figure 1 Custom bed designed for dual-modality preclinical
imaging of the knee. Non-ferromagnetic plastic was used to
position the rat with its knees extended. Upon completion of an
MRI scan, the surface coil was retracted and a tissue calibration
phantom (not shown) was placed along the joint line. The animal
remained splinted to the bed for both MRI and micro-CT imaging
sessions, which inhibited knee flexion and improved image
registration. micro-CT, micro computed tomography; MRI, magnetic
resonance imaging.
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was achieved from the average of the mean score of all
slides (≥ 3) for each joint surface.
Chemical reagents were purchased from Sigma-
Aldrich (Oakville, ON, CA), unless stated otherwise.
Antibodies were purchased from Abcam (alkaline phos-
phatase - ALPL # ab95462; Cathepsin K # ab37259,
Cambridge, MA, US), and Santa Cruz (HRP conjugated
goat anti-mouse # sc-2005, HRP conjugated goat anti-
rabbit # sc-2004, Santa Cruz, CA, US). DAB substrate-
chromogen was purchased from Dako (K3468, Burling-
ton, ON, CA). Knee joint sections, each 5 μm thick,
were dewaxed, re-hydrated (xylene, 100% ethanol, 95%,
70% and H2O), and stained with hematoxylin and eosin,
Safranin O and fast green and Picrosirius red, using
standard protocols [30,31].
Immunohistochemistry protocols were performed as
previously described [32] with some modifications.
Rehydrated sections were incubated in 3% hydrogen
peroxide for 15 minutes at room temperature, followed
by heat antigen retrieval; the slides were incubated with
preheated (2 minutes at 100°C) 10 mM sodium citrate
solution (pH = 6.0) for 30 minutes at 97°C (for ALPL
antibody). In the case of Cathepsin K antibody, incuba-
tion with 0.1% TritonX-100 for 10 minutes was used for
antigen retrieval. Subsequently, they were blocked with
5% goat serum and incubated with primary antibodies
against ALPL and cathepsin K over night at 4°C, fol-
lowed by HRP conjugated- secondary antibody for
1 hour at 4°C. After washing, the sections were incu-
bated for 2 to 5 minutes with diaminobenzidine (DAB)
substrate solution, washed and mounted. Counter-stain-
ing was performed with methyl green for 5 minutes,
which was followed by dehydration and mounting of the
sections. Images were taken with a Retiga EX camera
(QImaging, Surrey, BC, CA), connected to a DMRA2
microscope (Leica microsystems, Wetzlar, Hesse, DE).
Primary image analyses were performed using Openlab
4.0.4 and Adobe Photoshop software.
Statistical Analysis
Quantitative values for SBC diameter were compared
using a one-way analysis of variance (ANOVA) with a
Tukey’s post-hoc test as there were unequal n-values per
time point due to the formation of additional SBC
detected after four weeks post-ACLX. The vBMD data
above the SBC that appeared throughout the whole course
of the study were compared using a repeated measures
ANOVA. Differences for each parameter, between all time
points, were considered significant for P < 0.05. The
OARSI grade, between the ACLX and contralateral limb
of the same animal, was compared using a Wilcoxon
signed rank test.
Results
Incidence and Appearance of SBC
The in vivo, dual-modality imaging protocol was com-
pleted in less than one hour using a single dose of anes-
thetic. The reconstructed and registered data sets provided
excellent visualization of the major structural components
in the rat knee including the subchondral bone, articular
cartilage, and meniscus, which contains both bone and
non-bone components (Figure 2). The presence of SBC
was found in all animals throughout the time-course of
the study (12 weeks) and primarily occurred in the medial
tibial plateau (MTP). Some SBC were identified within the
medial femoral compartment, however these occurred less
Figure 2 Dual-modality imaging in an in vivo preclinical model of OA. Sagittal (a, b) and coronal (c, d) plane images of the rat knee
obtained from co-registered high-field MRI (a, c) and micro-CT (b, d). The MRI volume was resampled to isotropic voxel dimensions prior to co-
registration, which allowed the delineation of bone and non-bone components in the meniscus (MN) and the accurate depiction of tendon (PT,
patellar tendon), ligament (ACL, anterior cruciate ligament), and cartilage (horizontal arrowheads). ROI, region of interest, identifies approximate
location where volumetric bone mineral density was calculated above the SBC. micro-CT, micro computed tomography; MRI, magnetic
resonance imaging; OA, osteoarthritis.
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frequently, and therefore we will only discuss SBC within
the MTP. Focal areas of bone resorption, with subsequent
loss of bone mineral density (Table 1), were identified
initially in the micro-CT volume among 6 of 8 rat knees
(75%) at 4 weeks post-ACLX, and all knees contained at
least one cyst by the endpoint. In addition, a second cyst
appeared in 63% (that is 5 out of 8) of ACLX rats by the
final time point (12 weeks). No intra-osseous lesions were
found in the contra-lateral (non-operated) limb of ACLX
animals throughout the study. The SBC were primarily
pyriform or spherical shaped and were located underneath
a breach of the subchondral bone plate (Figure 3) that was
defined as an open communication between the joint
space and trabecular bone through the subchondral plate,
and was more easily distinguished in the micro-CT
volume due to its higher spatial resolution (Figure 3a).
The MRI revealed a heterogeneous signal within the SBC
that was higher at earlier time points, though not as high
as cartilage, and gradually degraded over time revealing a
transition from a more fluid-filled to fibrous-filled cavity
(Figure 3b, c). The mean diameter of the SBC significantly
increased over time (P = 0.013), and Tukey’s post-test
revealed a significantly larger diameter at 12 weeks post-
ACLX versus 4 weeks (Figure 4, P < 0.05). The micro-CT
derived SBC diameters were usually higher than the MRI
measurements (Table 1), though overall the values agreed
within 10%.
Quantitative and Histological Analysis
vBMD was calculated within the superficial subchondral
bone with cylindrical ROIs that had a total volume of
approximately 0.070 mm3. Repeated measure ANOVA
revealed that the mean vBMD per time point was signif-
icantly different (Table 1, P = 0.027) immediately above
the SBC. Tukey’s post-hoc test indicated that the
decreased vBMD 8 weeks post-ACLX was significantly
lower than presurgical values (P < 0.05). At 12 weeks
post-ACLX, there was a 13% increase in peri-cystic
vBMD versus 8 weeks post-ACLX; although it was not
considered statistically significant (Table 1), this
increased vBMD indicated ongoing bone remodelling.
The OARSI score for the ACLX knees was significantly
higher (P = 0.008) than the contralateral knee of the
same animal (Table 1). In addition, the SBC were
located at the site within the histological section that
received the highest (that is, the most severe OA) grade,
often accompanied by superficial or deep lesions and
severe proteoglycan loss within the cartilage itself
(Figure 5, 6, Additional file 1). Although difficult to
identify in every section, a connection or breach of the
subchondral plate was confirmed for all SBC located
near the joint space (Figure 5c). However, these gaps
were not an open communication with the joint space
that could allow fluid exchange, but were rather filled
with a fibrous or cartilaginous tissue, which seemed
reparative. Areas of bone surrounding the SBC appeared
necrotic and lacked any normal marrow components
when compared with the contralateral limb (Figure 6,
Additional files 1, 2). Moreover, there was no epithelial
lining observed along the SBC margins. Immunohisto-
chemistry revealed that even at an advanced stage of
OA, evidenced by the near complete loss of cartilage,
the area surrounding the SBC was still undergoing bone
remodeling, with increased markers for both osteoblasts
(ALPL) and osteoclasts (cathepsin K) (Figure 7).
Discussion
To the best of our knowledge, this is the first study to
indentify and monitor SBC as they occur in a preclinical
model of OA. The induction of OA through surgical
destabilization in the rat knee produced SBC in a con-
sistent manner within the medial tibial plateau, which
could be measured with medical imaging techniques
similar to those used in humans. High-field MRI aided
in the depiction of SBC having both fluid and fibrous
tissue components as they increased in size and number
and the rapid acquisition time enabled us to obtain an
in vivo, dual-modality images of the rat knee in under
an hour. Using histological analyses and a grading sys-
tem of OA severity designed for humans [33], we found
that SBC occur at the site of greatest disease severity,
which agrees with previous findings in humans [21].
This study further validates the rat ACLX model of sec-
ondary OA with SBC development.
Table 1 Descriptive statistics for all operated (ACLX) knees containing subchondral bone cysts (SBC) (Number = 8)
Time post-ACLX CT diameter (mm) MRI diameter (mm) vBMD (mg/cc) OARSI grade
Presurgical 770 ± 19
4 weeks 0.626 ± 0.126 0.656 ± 0.0781 680 ± 52
8 weeks 0.922 ± 0.111 0.827 ± 0.105 610 ± 37*
12 weeks 1.14 ± 0.0923* 1.07 ± 0.0809* 690 ± 57 18 ± 0.82
2.9 ± 0.58
Values are mean ± standard error from the measured SBC diameter and superficial volumetric bone mineral density (vBMD) occurring over time. OA grade
(OARSI), acquired from the histological analysis, is provided for the final time point only and presented versus the contralateral limb score underneath. *vBMD =
P < 0.05 versus presurgical, *diameter = P < 0.05 versus 4 weeks. ACLX, anterior cruciate ligament transection with partial medial meniscectomy; CT, computed
tomography; MRI, magnetic resonance imaging; OARSI, Osteoarthritis Research Society International.
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The presence of a breached subchondral plate was
identified by Landells and proposed to be the source of
SBC formation [16]. As synovial fluid entered the cavity,
it was thought to increase the intra-osseous pressure and
lead to subsequent cyst expansion. However, this is unli-
kely for the following reasons: the defect in the subchon-
dral plate is small relative to the size of the SBC (Figure
5c); the course, if it existed, from joint space to SBC is
tortuous or oblique to the surface, limiting the ability of
easy fluid exchange (Figure 5c); the defect is filled with
fibro-cartilage (Figure 5c, 7a), which is less stiff than
bone, but may not allow fluid flow in the same manner
as hyaline cartilage behaves as a viscoelastic solid under
weight-bearing. In addition, as the SBC were still expand-
ing by the final time point, there was evidence of imma-
ture bone deposition in some knees that would further
inhibit fluid flow (Figure 3f). Thus, Ondrouch proposed
that due to a thinned cartilage layer, normal weight-bear-
ing forces within the adjacent bone are increased beyond
its physiological limits, causing focal damage, subsequent
resorption and SBC formation [15]. Recent mechanical
simulation studies have confirmed higher intra-osseous
stress values beneath the joint surface when the amount
of overlying cartilage is diminished [17], which could also
lead to SBC formation in the opposing bone in the joint.
Our results indicate that the SBC are developing and
expanding due to the mechanical instability imposed by
the ACLX. Increased shear stress on the surface of the
cartilage, due to the loss of the ligament, combined with
a medial compartment-weight distribution bias, due to
the meniscectomy, caused cartilage reduction or fibrilla-
tion and increased intra-osseous stress simultaneously.
Figure 3 Longitudinal monitoring of subchondral bone cysts (SBC) developing in the medial tibial plateau. Co-registered sagittal 9.4
Tesla MRI (a-c) and micro-CT (d-f) sections reveal the onset of SBC formation in conjunction with a breach of the subchondral bone plate (d -
arrowhead), which never fully repairs over time. All SBC expanded over time, 4 weeks (wk) to 12 wk post surgery, and appeared to transition
from a vacuous, fluid filled cavity (b - arrow) to a more fibrous filled region containing immature or disorganized osteoid (c, f - arrows). Scale
bar = 2 mm. micro-CT, micro computed tomography; MRI, magnetic resonance imaging.
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Therefore, the defect in the subchondral bone is likely a
micro-fracture in response to the overloaded region in
the joint. Repeated loading of this area during gait pre-
vents sufficient healing and the space remains occupied
with fibrous tissue (Figures 6, 7). Consequently, the bone
below undergoes further damage leading to focal osteo-
necrosis, which is defined as a lack of osteocytes in the
damaged area followed by the formation of fibrotic, avas-
cular marrow [34,35].
The expansion of these SBC in OA joints occurs due
to stress-induced bone resorption of necrotic tissue. In
the hip, this can continue until the majority of the epi-
physeal trabecular bone in the femoral head or acetabu-
lum is resorbed, causing great pain and deformity
[14,16,17]. The SBC in knee OA tend to be smaller and
contain an outer rim of sclerotic bone that makes them
distinguishable even when imaged with planar radio-
graphs [13,36]. This may indicate a form of self-limita-
tion within the bone, where the SBC become more
spherical and are surrounded by a necrotic shell to help
dissipate the increased loading. This may explain how
some SBC can resolve or reduce in size over time [21] if
the fibro-cartilage tissue within the cavity is provided
the opportunity to mineralize. Sclerotic bone formation
is emulated in our rat model as vBMD increased by 13%
(at 12 weeks post-ACLX) on the superficial surface of
the SBC after a significant decrease in vBMD at 8 weeks
post-ACLX versus presurgical values. Furthermore,
simulations of SBC within the human knee using finite-
Figure 4 Mean maximal diameter of subchondral bone cysts
(SBC) in the medial tibial plateau for all rodents post surgery.
Points represent the SBC measured in the coronal plane using
micro-CT at each time point. Repeated measures ANOVA found the
diameter increased significantly at 3 months post-ACLX (anterior
cruciate ligament with partial medial menisectomy) versus the 1-
month time point (*P < 0.05). ANOVA, analysis of variance; micro-CT,
micro computed tomography.
Figure 5 Identification of the subchondral bone plate breach found in subchondral bone cysts (SBC) in the OA rat knee. Sagittal micro-
CT (a) and high-field MRI (b) sections were used to observe and monitor SBC in vivo. End stage histological analysis confirmed separation in the
subchondral bone plate (c - arrow, 10 × magnification of Safranin-O with fast-green counter stain). Note, the fibrocartilage repair tissue adjacent
the SBC (horizontal arrowheads) and breach to the subchondral plate. Remaining bone tissue between the repair tissue and the SBC lacks the
presence of osteocytes (vertical arrowhead) that indicates focal necrosis. Note the ‘pear’ shape of the intra-osseous lesion, consistent with SBC in
humans. micro-CT, micro computed tomography; MRI, magnetic resonance imaging; OA, osteoarthritis.
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Figure 6 Safranin-O stained histological section of the operated (ACLX) and un-operated knee (LEFT) 3 months post-surgery. Note, the
remaining fragment of trabecular bone (left, arrow) within the cyst region and the lack of viable osteocytes within the surrounding bone
(arrowheads), which indicates focal osteonecrosis. Scale bar = 250 μm. ACLX, anterior cruciate ligament transection with partial medial
meniscectomy.
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Figure 7 Histological characterization of cyst development in a rodent model of Osteoarthritis. Immunohistochemistry revealed an active
bone remodeling response within the subchondral bone cysts (SBC), as the anterior cruciate ligament transection with partial medical
menisectomy (ACLX - a, c, e) knees showed greater staining for markers of both resorption (Cathepsin K, a-arrow), and bone formation (Alkaline
phosphatase, c-arrowheads) against the un-operated knees of the same animals (LEFT, b, d, f). Hematoxylin and eosin staining (e, f) showed the
SBC (3 months post-ACLX) as a fibrous cavity, with fibrotic bone marrow in the ACLX knee (e-arrowheads). Scale bar = 250 μm.
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element analysis indicated that intra-osseous stress con-
centrations were higher near the joint surface [28],
which could explain the sclerotic bone formation seen
in the proximal tibia (Figure 2f).
One of the features lacking in our SBC models was the
detectable presence of bone marrow edema, which is
commonly associated with human SBC development
[18-20]. A diffuse, and high-intensity fluid-like, signal
upon MRI examination of the trabecular bone is the pro-
posed evidence of edema in the joint compartment, typi-
cally as a result of injury and the subsequent initiation of
the bone remodeling process [20]. Edema has been found
to precede SBC formation in most cases [20,21], but its
presence does not guarantee trabecular remodeling when
compared with histological examination [37]. The inabil-
ity to detect bone edema may have resulted from the
MRI sequence used, as it did not incorporate fat suppres-
sion techniques that enhance edema visualization against
the fatty bone marrow [38]. However, we were concerned
about masking any marrow components that may be
included within the SBC and chose not to use fat sup-
pression in our MRI protocol. In addition, allowing a
shorter duration between imaging sessions (that is, two
weeks) may improve our detection of edema in the early
stages of OA progression and SBC formation. With the
advancement of custom designed rat knee coils [39] that
incorporate longer scan times for increased signal-to-
noise ratio, it will be feasible to further quantify the tissue
composition of SBC over time, without reliance on tis-
sue-destructive, end-stage histological analysis. This is
further evident in the recent work using the rat model of
secondary OA, combined with dual-modality imaging
that demonstrated the utility of longitudinal imaging
when evaluating the effect of anti-inflammatory drugs on
disease progression [23].
Conclusions
In summary, the rat ACLX model of post-traumatic knee
OA provides valuable insights into the cause and composi-
tion of a degenerative feature within the subchondral bone
that is associated with greater pain and disease severity.
Subchondral cysts, as they are commonly referred to,
appeared in a predictable manner within the overloaded
joint compartment of the medial tibial plateau. These SBC
do not contain any evidence of an epithelial lining and
therefore are often referred to as ‘pseudo-cysts’ or geodes,
indicating the formation of a lesion in response to stress
[13,14]. Our evidence suggests that these spherical or pyri-
formal intra-osseous lesions contain fibrous tissue, which
may initially contain fluid and can ossify in later stages,
surrounded by regions that lack osteocytes and can possi-
bly form a sclerotic margin in response to repeated, patho-
logical loads. Therefore, we feel further studies are
warranted to elucidate the unique pathogenesis of SBC
that focus on the presence of focal, OA-induced osteone-
crosis. A breach of the subchondral bone plate was found
overlying all SBC and we believe the expansion of these
SBC is more likely due to micro-fracture and stress-
induced bone resorption than the influx of fluid through
the breach. It remains unclear whether SBC first initiate
due to a loss of cartilage integrity or as a result of a sub-
chondral bone failure, but this debate is common in OA
research and future studies should strive to characterize
the response of both tissues to pathological stress
conditions.
In addition, it should be noted that SBC tended to
appear in combination with greater cartilage severity
scores. Finally, in vivo dual-modality imaging proved an
invaluable method for quantifying the efficacy of thera-
peutic interventions developed to treat SBC in humans
[40] or animals [23].
Additional material
Additional file 1: Coronal section of the OA rat knee stained with
Picrosirius Red (5× magnification). Subchondral cysts (SBC) within the
medial tibial plateau stained positively for the presence of collagen
within the lesion itself (black arrows). This confirms that the composition
of the focal areas of bone loss, observed in co-registered micro-CT and
MRI images, have a different composition than the normal marrow
(yellow arrow). SBC appeared adjacent to the joint surface and were
characteristically found in the region of the knee with the most severe
cartilage degradation.
Additional file 2: Hematoxylin-eosin stain of the operated (ACLX)
and un-operated (LEFT) knee of the same rat, 12 weeks post-
surgery (10× magnification). Note the disorganization of the trabecular
bone seen in the ACLX (arrow) versus the LEFT knee that occurred
immediately adjacent the subchondral bone cyst (SBC).
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